Cencora Inc. (COR) Balance Sheet

A balance sheet shows what a company owns and owes, and shareholders' equity, at a single point in time.

Cencora, Inc. sources and distributes pharmaceutical products in the United States and internationally. The company's U.S.

Total Assets Chart for Cencora Inc.

Cencora Inc. (COR) total assets for FY2025 were USD 76.6B, a 14.1% change from FY2024. Cencora Inc.'s total assets grew from USD 711.6M in 1994 to USD 76.6B in 2025 (10663.1% over 31 years). Total assets compound annual growth rate: 5-year CAGR of 11.6%, 10-year CAGR of 10.7%, 20-year CAGR of 10.0%.

The most recent 3 years are real; the rest is blurred as a preview. Sign up free to unlock every line item, quarterly data, and the real full history. Free account: 8 years of history for 10 flagship companies. Premium: full history for 500+ companies. Premium is €10.00/month. See pricing.

Total Assets (US Dollars)

R&D as % of Revenue

Compare with

Key Stats

Market Cap
$62.02B
Implied Share Price
$325.01
Enterprise Value
$70.78B
Revenue (TTM)
$332.77B
EBITDA
$5.33B
Profit Margin
0.79%
Trailing P/E
24.11
Forward P/E
15.55
Price/Book (MRQ)
17.83
Price/Sales (TTM)
0.19
EV/EBITDA
14.07
EV/Revenue
0.22
Dividend Yield
0.17%
Book Value
$17.46
Free Cash Flow (FY2025)
$3.21B
Free Cash Flow Yield
5.17%

Snapshot as of 7th August 2026 — not point-in-time controlled, may lag the live market by a few days.